Posted by Reuters: Business News on March 22, 2011
PARIS/LONDON (Reuters) – Regulatory pressure prompted Sanofi-Aventis and Merck & Co to abandon plans for a joint animal health powerhouse with $5 billion in sales.
Posted by Reuters: Business News on February 16, 2011
PARIS (Reuters) – French drugmaker Sanofi-Aventis SA clinched its long-sought deal for Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the U.S. biotech…
Posted by Reuters: Business News on
NEW YORK (Reuters) – U.S. stocks rose on Wednesday after estimate-beating results from technology bellwether Dell and a deal for Sanofi-Aventis to buy Genzyme for $20.1 billion in cash.
Posted by Reuters: Business News on
NEW YORK (Reuters) – Stock index futures rose on Wednesday after estimate-beating results from Dell and a deal for Sanofi-Aventis to buy Genzyme for $20.1 billion in cash.
Posted by Reuters: Business News on
PARIS (Reuters) – French drugmaker Sanofi-Aventis SA agreed to buy Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the U.S. biotech group’s drugs, the…
Posted by Reuters: Business News on
PARIS (Reuters) – French drugmaker Sanofi-Aventis SA agreed to buy Genzyme Corp with a sweetened $20.1 billion cash offer, plus payments tied to the success of the U.S. biotech group’s drugs, the…
Posted by Reuters: Business News on
PARIS (Reuters) – French drugmaker Sanofi-Aventis SA agreed to buy Genzyme Corp for $20.1 billion in cash, plus payments tied to the success of the U.S. biotech group’s drugs, the companies said on…
Posted by Reuters: Business News on
BOSTON/PHILADELPHIA (Reuters) – Sanofi-Aventis SA has reached an agreement in principle to buy Genzyme Corp for about $19 billion in cash plus future payments based on the performance of an…
Posted by Reuters: Business News on February 9, 2011
PARIS (Reuters) – Sanofi-Aventis reported progress in talks to buy U.S. biotech Genzyme and predicted 5-10 percent lower earnings in 2011, underscoring the French drugmaker’s need to find new sources…
Posted by Reuters: Business News on February 7, 2011
PARIS/BOSTON (Reuters) – France’s Sanofi-Aventis was closing in on a roughly $20 billion deal to buy U.S. biotech group Genzyme while pausing to take a final look at the books, sources familiar with…
